Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 7;79(8):402.
doi: 10.1007/s00018-022-04433-9.

Age-associated B cells in autoimmune diseases

Affiliations
Review

Age-associated B cells in autoimmune diseases

Isobel C Mouat et al. Cell Mol Life Sci. .

Abstract

Age-associated B cells (ABCs) are a transcriptionally and functionally unique B cell population. In addition to arising with age and following infection, ABCs are expanded during autoimmune disease, including those with systemic lupus erythematosus, multiple sclerosis, and rheumatoid arthritis. The exact nature of how ABCs impact disease remains unclear. Here, we review what is known regarding ABC development and distribution during diseases including systemic lupus erythematosus, multiple sclerosis, and rheumatoid arthritis. We discuss possible mechanisms by which ABCs could contribute to disease, including the production of cytokines and autoantibodies or stimulation of T cells. Finally, we speculate on how ABCs might act as mediators between sex, infection, and autoimmune disease, and discuss avenues for further research.

Keywords: Age-associated B cell; Atypical B cell; Multiple sclerosis; Systemic lupus erythematosus; T-bet B cell.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Age-associated B cells in health versus autoimmune disease Age-associated B cells (ABCs) differentiate from a combination of signals that include BCR stimulation and TLR7/9 engagement, in addition to CD40, IFNγ, and IL-21 signals, likely provided by T follicular helper cells. During times of health, ABCs are maintained at low levels in the spleen, bone marrow, and circulation, and are nearly undetectable in tonsil and lymph nodes. During autoimmune disease, ABC quantity is increased, and ABCs circulate and are present at the site of disease. ABCs produce anti-viral antibodies and cytokines in healthy individuals during viral infection. During autoimmune disease, ABCs produce both protective and inflammatory cytokines, stimulate T cells, and produce autoantibodies.

References

    1. Alshaiki F, Obaid E, Almuallim A, Taha R, El-Haddad H, Almoallim H. Outcomes of rituximab therapy in refractory lupus: a meta-analysis. Eur J Rheumatol. 2018;5(2):118–126. doi: 10.5152/eurjrheum.2018.17096. - DOI - PMC - PubMed
    1. Novi G, Bovis F, Fabbri S, et al. Tailoring B cell depletion therapy in MS according to memory B cell monitoring. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e845. doi: 10.1212/NXI.0000000000000845. - DOI - PMC - PubMed
    1. Chisari CG, Sgarlata E, Arena S, Toscano S, Luca M, Patti F. Rituximab for the treatment of multiple sclerosis: a review. J Neurol. 2021 doi: 10.1007/s00415-020-10362-z. - DOI - PMC - PubMed
    1. Looney RJ, Anolik JH, Campbell D, et al. B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab. Arthritis Rheum. 2004;50(8):2580–2589. doi: 10.1002/art.20430. - DOI - PubMed
    1. Edwards JCW, Szczepanski L, Szechinski J, et al. Efficacy of B cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med. 2004;350(25):2572–2581. doi: 10.1056/NEJMoa032534. - DOI - PubMed